A Molecule That Suppresses Cancer Metastasis Has Been Discovered

One of the 10 hallmarks of cancer is the migration of cancer cells to different tissues and organs. Metastasis , as this process is called, accounts for 90 percent of cancer-related deaths. A study published in May 2018 in Sciencefound that the molecule metarrestin prevents metastasis by disrupting the nuclear structure of cancer cells , thereby stopping their spread.
Cancer is particularly challenging to treat when it migrates to different tissues and organs. Most drugs currently used try to inhibit cancer cell proliferation. However, there is no drug approved for clinical use that directly targets metastasis. Metastasis is one of the most extensively studied topics in cancer research. Recently, researchers have been examining the role of the cancer cell nucleus and its various structures in cancer metastasis. One such structure, the perinucleolar compartment , is found in cancer cell nuclei. Laboratory studies identified these structures in cancer cells obtained from human tumors. Cells with this structure were also found to have a greater ability to metastasize. This led to the idea that targeting the perinucleolar compartment might effectively prevent metastasis.
Researchers at Northwestern University in the United States analyzed 140.000 molecules using a special method to identify the molecule that most effectively destroys the perinucleolar compartment in metastatic cancer cells.
According to the Study Results:
A molecule that effectively identified the perinucleolar compartment was discovered. Its chemical structure was modified and it was named metarrestin. Metarrestin significantly inhibited metastasis in mouse models transplanted with human pancreatic, breast and prostate cancer cells.
What Does This Study Mean for Us?
- An important molecule aimed at preventing metastasis, the leading cause of death from cancer, has been discovered. This molecule was analyzed using modern drug discovery methods.
- Metarrestin shows promise for preventing metastasis. Researchers plan to apply to the United States Food and Drug Administration FDAnew drug discovery program within the year.
- It must be emphasized that these are the initial results of laboratory experiments. Further analyses are needed to confirm the molecule's effectiveness. It may become a drug after clinical trials in humans. Modern medicine adds new cancer treatments every day through the contributions of different scientific disciplines. Cancer treatment and management are only possible through the opportunities offered by modern medicine.
Sources
Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis.
Science Translational Medicine, May 2018.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.